secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001171843-24-002270
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq confirms Aptose regained compliance with Listing Rule 5635(d) after warrant amendment
--------------------------------------------------------------------------------

- Aptose and Hanmi amended warrant to cap exercise at 19.99% of outstanding shares without shareholder approval.
- Hanmi received 2,339,181 warrants at $1.71/share, exercisable for 5 years from issuance.
- Nasdaq Staff determined compliance with Rule 5635(d) regained; matter closed.
- Original violation stemmed from Jan 25, 2024 Hanmi transaction that issued >20% shares at a discount.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184324002270/0001171843-24-002270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184324002270/f8k_042624.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer